476 related articles for article (PubMed ID: 29022265)
1. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
Mahmoud AM
Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
[TBL] [Abstract][Full Text] [Related]
2. How exercise may amend metabolic disturbances in diabetic cardiomyopathy.
Hafstad AD; Boardman N; Aasum E
Antioxid Redox Signal; 2015 Jun; 22(17):1587-605. PubMed ID: 25738326
[TBL] [Abstract][Full Text] [Related]
3. Cardiac effects of HDL and its components on diabetic cardiomyopathy.
Spillmann F; Van Linthout S; Tschöpe C
Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):132-47. PubMed ID: 22236025
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
5. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
6. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
7. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
Dhalla NS; Shah AK; Tappia PS
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
[TBL] [Abstract][Full Text] [Related]
8. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
Khan S; Ahmad SS; Kamal MA
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress: a key contributor to diabetic cardiomyopathy.
Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
[TBL] [Abstract][Full Text] [Related]
10. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
Falcão-Pires I; Leite-Moreira AF
Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in diabetic cardiomyopathy.
Duncan JG
Biochim Biophys Acta; 2011 Jul; 1813(7):1351-9. PubMed ID: 21256163
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas.
Guido MC; Marques AF; Tavares ER; Tavares de Melo MD; Salemi VMC; Maranhão RC
Oxid Med Cell Longev; 2017; 2017():5343972. PubMed ID: 28781721
[TBL] [Abstract][Full Text] [Related]
14. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
Parim B; Sathibabu Uddandrao VV; Saravanan G
Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
[TBL] [Abstract][Full Text] [Related]
15. High-Intensity Exercise Reduces Cardiac Fibrosis and Hypertrophy but Does Not Restore the Nitroso-Redox Imbalance in Diabetic Cardiomyopathy.
Novoa U; Arauna D; Moran M; Nuñez M; Zagmutt S; Saldivia S; Valdes C; Villaseñor J; Zambrano CG; Gonzalez DR
Oxid Med Cell Longev; 2017; 2017():7921363. PubMed ID: 28698769
[TBL] [Abstract][Full Text] [Related]
16. Updating experimental models of diabetic cardiomyopathy.
Fuentes-Antrás J; Picatoste B; Gómez-Hernández A; Egido J; Tuñón J; Lorenzo Ó
J Diabetes Res; 2015; 2015():656795. PubMed ID: 25973429
[TBL] [Abstract][Full Text] [Related]
17. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Huynh K; Bernardo BC; McMullen JR; Ritchie RH
Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
[TBL] [Abstract][Full Text] [Related]
18. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets.
Sung MM; Hamza SM; Dyck JR
Antioxid Redox Signal; 2015 Jun; 22(17):1606-30. PubMed ID: 25808033
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
[TBL] [Abstract][Full Text] [Related]
20. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential.
Faria A; Persaud SJ
Pharmacol Ther; 2017 Apr; 172():50-62. PubMed ID: 27916650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
